Cyclosporine A and IFNγ licencing enhances human mesenchymal stromal cell potency in a humanised mouse model of acute graft versus host disease

Overview of attention for article published in Stem Cell Research & Therapy, April 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (55th percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 33,888 followers.

RT @KEnglishLab: The most recent paper from our lab. Congrats to @JenMCorbett @HazelDunbar_ and Ian Hawthorne @MaynoothBiology . Another @I…

RT @KEnglishLab: The most recent paper from our lab. Congrats to @JenMCorbett @HazelDunbar_ and Ian Hawthorne @MaynoothBiology . Another @I…

The most recent paper from our lab. Congrats to @JenMCorbett @HazelDunbar_ and Ian Hawthorne @MaynoothBiology . Another @IrishResearch funded project to @JenMCorbett under an EPS with @IvanCoulter from Sigmoid Pharma Days #CellTherapy #MesenchymalStromalCe

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.